You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 148 No. 1, January 1994 TABLE OF CONTENTS
  Archives
  •  Online Features
  Articles
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Eradication of Haemophilus influenzae Type b Disease in Southern California

constance M. Vadheim, PhD; David P. Greenberg, MD; Eileen Eriksen, MPH; Leslie Hemenway; Nancie Bendana, PHN; Laurene Mascola, MD; Joel I. Ward, MD; The Kaiser-UCLA Vaccine Study Group

Arch Pediatr Adolesc Med. 1994;148(1):51-56.


Abstract

Objective
To assess the effects of Haemophilus influenzae vaccination of infants.

Research Design
We evaluated H influenzae type b (Hib) disease rates in Los Angeles County, California (population, 9 million; 1983 through 1992), and in the Southern California Kaiser Health Plan (2.5 million enrollees; 1988 through 1992) during the past decade. Cases were obtained through active and passive disease surveillance in the two populations. The following vaccines were used during the study period (1983 through 1992): (1) Hib polysaccharide vaccine (polyribosyl ribitol phosphate) (used from 1985 through 1987 for children 24 through 60 months of age); (2) Hib polysaccharide-diphtheriatoxoid conjugate, Hib polysaccharide CRM197 mutant diphtheria toxoid conjugate vaccine, and Hib polysaccharide outer-membrane protein of group B meningococcus conjugate vaccine in older children (1988 through 1990; ages 15 through 60 months); and (3) Hib polysaccharide CRM197 mutant diphtheria toxoidconjugate vaccine and Hib polysaccharide outer-membrane protein of group B meningococcus conjugate vaccine used in infants (1991 through 1992).

Measurements and Results
Between 1983 and 1988, the Hib disease incidence in Los Angeles County was unchanged (32.7 to 42.5/100 000 person-years in children younger than 5 years). In 1989 through 1990, before Hib conjugate licensure for infant use, Hib disease rates in all age groups declined. After licensure of Hib vaccines for infants in 1990, there was a further fivefold decrease in infants. More dramatic decreases occurred in the better-immunized Kaiser Health Plan children aged 0 through 60 months (53 cases in 1989, only two cases in 1992).

Conclusions
The Hib disease has been nearly eradicated in a fully immunized population (Kaiser Health Plan), and significant reductions have also occurred in Los Angeles County.

(Arch Pediatr Adolesc Med. 1994;148:51-56)



Author Affiliations

From the UCLA Center for Vaccine Research, Research and Education Institute, Harbor-UCLA Medical Center, Torrance, Calif (Drs Vadheim, Greenberg, and Ward and Mss Eriksen and Hemenway); Acute Communicable Disease Division, Los Angeles County Health Department, Los Angeles, Calif (Ms Bendana and Dr Mascola); and the Kaiser Foundation Hospitals and Medical Clinics.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Outcomes Research in Pediatric Settings: Recent Trends and Future Directions
Forrest et al.
Pediatrics 2003;111:171-178.
ABSTRACT | FULL TEXT  

Worldwide Haemophilus influenzae Type b Disease at the Beginning of the 21st Century: Global Analysis of the Disease Burden 25 Years after the Use of the Polysaccharide Vaccine and a Decade after the Advent of Conjugates
Peltola
Clin. Microbiol. Rev. 2000;13:302-317.
ABSTRACT | FULL TEXT  

Three-Year Multicenter Surveillance of Pneumococcal Meningitis in Children: Clinical Characteristics, and Outcome Related to Penicillin Susceptibility and Dexamethasone Use
Arditi et al.
Pediatrics 1998;102:1087-1097.
ABSTRACT | FULL TEXT  

Haemophilus influenzae Invasive Disease Among Children Aged <5 Years--California, 1990-1996
JAMA 1998;280:1130-1131.
FULL TEXT  

Do Oral Antibiotics Prevent Meningitis and Serious Bacterial Infections in Children With Streptococcus pneumoniae Occult Bacteremia? A Meta-analysis
Rothrock et al.
Pediatrics 1997;99:438-444.
ABSTRACT | FULL TEXT  

Methodological Issues in Determining Rates of Childhood Immunization in Office Practice: A Study From Pediatric Research in Office Settings (PROS)
Darden et al.
Arch Pediatr Adolesc Med 1996;150:1027-1031.
ABSTRACT  

Sudden Infant Death Syndrome and Haemophilus influenzae Infection
Sepkowitz
Arch Pediatr Adolesc Med 1994;148:1109-1110.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.